Your browser doesn't support javascript.
loading
Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma.
Hannan, Raquibul; Mohamad, Osama; Diaz de Leon, Alberto; Manna, Subrata; Pop, Laurentiu M; Zhang, Ze; Mannala, Samantha; Christie, Alana; Christley, Scott; Monson, Nancy; Ishihara, Dan; Hsu, Eric J; Ahn, Chul; Kapur, Payal; Chen, Mingyi; Arriaga, Yull; Courtney, Kevin; Cantarel, Brandi; Wakeland, Edward K; Fu, Yang-Xin; Pedrosa, Ivan; Cowell, Lindsay; Wang, Tao; Margulis, Vitaly; Choy, Hak; Timmerman, Robert D; Brugarolas, James.
Afiliación
  • Hannan R; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas. Raquibul.Hannan@UTSouthwestern.edu.
  • Mohamad O; Kidney Cancer Program, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Diaz de Leon A; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Manna S; Department of Radiation Oncology, University of California San Francisco, San Francisco, California.
  • Pop LM; Kidney Cancer Program, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Zhang Z; Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Mannala S; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Christie A; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Christley S; Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Monson N; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Ishihara D; Kidney Cancer Program, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Hsu EJ; Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Ahn C; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Kapur P; Department of Neurology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Chen M; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Arriaga Y; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Courtney K; Kidney Cancer Program, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Cantarel B; Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Wakeland EK; Kidney Cancer Program, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Fu YX; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Pedrosa I; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Cowell L; Kidney Cancer Program, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Wang T; Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Margulis V; Kidney Cancer Program, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Choy H; Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Timmerman RD; Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Brugarolas J; Department of Immunology, University of Texas Southwestern Medical Center, Dallas, Texas.
Clin Cancer Res ; 27(24): 6716-6725, 2021 12 15.
Article en En | MEDLINE | ID: mdl-34551906

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Neoplasias Renales / Neoplasias Pulmonares Límite: Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article